ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer's and related diseases, today announced that the Simoa® ALZpath pTau217 Assay was used in a landmark population-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback